You are here

Article Text

Article menu

other Versions

Download PDFPDF
DTB select
Safety update: monitoring patients taking amiodarone

Abstract

Overview of: Medicines and Healthcare products Regulatory Agency. Amiodarone (Cordarone X): reminder of risks of treatment and need for patient monitoring and supervision. Drug Safety Update 2022;15:5-7.

  • Health Care Quality, Access, and Evaluation
  • Drug-Related Side Effects and Adverse Reactions

https://doi.org/10.1136/dtb.2022.000034

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors DTB Team.

    • Provenance and peer review Commissioned; internally peer reviewed.